A caspase-7 that is encoded in the genome of human. [PRO:CNA, UniProtKB:P55210]
Drug | Taxonomy | Measurement | Average (mM) | Bioassay(s) | Publication(s) |
dihydroxyphenylalanine | Homo sapiens (human) | Potency | 15.8489 | 1 | 0 |
4-amino-1,8-naphthalimide | Homo sapiens (human) | Potency | 7.9433 | 1 | 0 |
amsacrine | Homo sapiens (human) | Potency | 15.8489 | 1 | 0 |
bithionol | Homo sapiens (human) | Potency | 31.6228 | 1 | 0 |
dipyridamole | Homo sapiens (human) | Potency | 3.9811 | 1 | 0 |
ellipticine | Homo sapiens (human) | Potency | 12.5893 | 1 | 0 |
gossypol | Homo sapiens (human) | Potency | 16.1303 | 3 | 0 |
harmaline | Homo sapiens (human) | Potency | 11.2947 | 1 | 0 |
harmalol | Homo sapiens (human) | Potency | 12.5893 | 1 | 0 |
hexachlorophene | Homo sapiens (human) | Potency | 31.6228 | 1 | 0 |
juglone | Homo sapiens (human) | Potency | 1.0000 | 1 | 0 |
mesalamine | Homo sapiens (human) | Potency | 16.5311 | 1 | 0 |
pomiferin | Homo sapiens (human) | Potency | 39.8107 | 1 | 0 |
propidium | Homo sapiens (human) | Potency | 2.5119 | 1 | 0 |
triamterene | Homo sapiens (human) | Potency | 12.8127 | 1 | 0 |
reserpine | Homo sapiens (human) | Potency | 7.9433 | 1 | 0 |
9,10-dimethyl-1,2-benzanthracene | Homo sapiens (human) | Potency | 31.6228 | 1 | 0 |
quinacrine monohydrochloride | Homo sapiens (human) | Potency | 3.9811 | 1 | 0 |
benzanthrone | Homo sapiens (human) | Potency | 15.8489 | 1 | 0 |
7,8-dimethyl-10-[(2R,3R,4S)-2,3,4,5-tetrahydroxypentyl]benzo[g]pteridine-2,4-dione | Homo sapiens (human) | Potency | 10.0000 | 1 | 0 |
acriflavine chloride | Homo sapiens (human) | Potency | 3.1623 | 1 | 0 |
aminacrine | Homo sapiens (human) | Potency | 12.5893 | 1 | 0 |
xanthone | Homo sapiens (human) | Potency | 25.1189 | 1 | 0 |
uvitex swn | Homo sapiens (human) | Potency | 12.5893 | 1 | 0 |
1,2-diaminobenzene | Homo sapiens (human) | Potency | 31.6228 | 1 | 0 |
pyrazolanthrone | Homo sapiens (human) | Potency | 3.1623 | 1 | 0 |
benzo(k)fluoranthene | Homo sapiens (human) | Potency | 6.3096 | 1 | 0 |
lithocholic acid | Homo sapiens (human) | Potency | 12.5893 | 1 | 0 |
rhein | Homo sapiens (human) | Potency | 25.1189 | 1 | 0 |
plumbagin | Homo sapiens (human) | Potency | 19.9526 | 1 | 0 |
2-anthramine | Homo sapiens (human) | Potency | 31.6228 | 1 | 0 |
ethidium bromide | Homo sapiens (human) | Potency | 6.3096 | 1 | 0 |
coralyne | Homo sapiens (human) | Potency | 3.9811 | 1 | 0 |
flupirtine | Homo sapiens (human) | Potency | 10.0000 | 1 | 0 |
topotecan hydrochloride | Homo sapiens (human) | Potency | 6.5812 | 1 | 0 |
toxoflavin | Homo sapiens (human) | Potency | 3.7636 | 3 | 0 |
7-amino-4-methylcoumarin | Homo sapiens (human) | Potency | 25.1189 | 1 | 0 |
coumarin 7 | Homo sapiens (human) | Potency | 0.1585 | 1 | 0 |
harmol hydrochloride | Homo sapiens (human) | Potency | 15.8489 | 1 | 0 |
quercetin 5,7,3',4'-tetramethyl ether | Homo sapiens (human) | Potency | 25.1189 | 1 | 0 |
10-hydroxycamptothecin | Homo sapiens (human) | Potency | 15.8489 | 1 | 0 |
7-amino-4-trifluoromethylcoumarin | Homo sapiens (human) | Potency | 3.9811 | 1 | 0 |
6-(6-methoxy-1,3-benzodioxol-5-yl)-7-furo[3,2-g][1]benzopyranone | Homo sapiens (human) | Potency | 19.9526 | 1 | 0 |
furamidine | Homo sapiens (human) | Potency | 3.9811 | 1 | 0 |
methotrexate | Homo sapiens (human) | Potency | 15.8489 | 1 | 0 |
isoteolin | Homo sapiens (human) | Potency | 31.6228 | 1 | 0 |
harmalol hydrochloride | Homo sapiens (human) | Potency | 3.1623 | 1 | 0 |
raubasine | Homo sapiens (human) | Potency | 25.1189 | 1 | 0 |
3-amino-4,6-dimethyl-2-thieno[2,3-b]pyridinecarboxylic acid ethyl ester | Homo sapiens (human) | Potency | 25.1189 | 1 | 0 |
nsc 663284 | Homo sapiens (human) | Potency | 3.1623 | 1 | 0 |
nsc354961 | Homo sapiens (human) | Potency | 3.9811 | 1 | 0 |
dactinomycin | Homo sapiens (human) | Potency | 31.6228 | 1 | 0 |
riboflavin | Homo sapiens (human) | Potency | 31.6228 | 1 | 0 |
2-Methylindole-3-acetic acid | Homo sapiens (human) | Potency | 39.8107 | 1 | 0 |
2-amino-3-cyano-5,6,7,8-tetrahydroquinoline-4-carboxylic acid methyl ester | Homo sapiens (human) | Potency | 15.8489 | 1 | 0 |
6-amino-2-methyl-8-phenyl-1,6,8,8a-tetrahydroisoquinoline-5,7,7-tricarbonitrile | Homo sapiens (human) | Potency | 15.8489 | 1 | 0 |
2-imino-N,8-dimethyl-5-oxo-1-propan-2-yl-3-dipyrido[1,2-d-3',4'-f]pyrimidinecarboxamide | Homo sapiens (human) | Potency | 1.5849 | 1 | 0 |
LSM-19079 | Homo sapiens (human) | Potency | 15.8489 | 1 | 0 |
3-amino-N-cyclopentyl-6-thiophen-2-yl-2-thieno[2,3-b]pyridinecarboxamide | Homo sapiens (human) | Potency | 19.9526 | 1 | 0 |
2-[[2-[[4-(2-furanylmethyl)-5-(phenylmethyl)-1,2,4-triazol-3-yl]thio]-1-oxoethyl]amino]-5,6-dihydro-4H-cyclopenta[b]thiophene-3-carboxamide | Homo sapiens (human) | Potency | 39.8107 | 1 | 0 |
5-(1,3-benzodioxol-5-yl)-N-(2-furanylmethyl)-7-(trifluoromethyl)-2-pyrazolo[1,5-a]pyrimidinecarboxamide | Homo sapiens (human) | Potency | 31.6228 | 1 | 0 |
5-(diethylsulfamoyl)-3-hydroxy-2-naphthalenecarboxylic acid | Homo sapiens (human) | Potency | 25.1189 | 1 | 0 |
11-[2-(4-morpholinyl)ethylamino]-7,8,9,10-tetrahydrobenzimidazolo[1,2-b]isoquinoline-6-carbonitrile | Homo sapiens (human) | Potency | 10.0000 | 1 | 0 |
3-(benzenesulfonyl)-2-imino-1-(2-oxolanylmethyl)-5-dipyrido[1,2-d-3',4'-f]pyrimidinone | Homo sapiens (human) | Potency | 12.5893 | 1 | 0 |
6-ethoxy-3-[[2-oxolanylmethyl-[[1-(2-phenylethyl)-5-tetrazolyl]methyl]amino]methyl]-1H-quinolin-2-one | Homo sapiens (human) | Potency | 31.6228 | 1 | 0 |
N-[2,5-dimethoxy-4-[[oxo(thiophen-2-yl)methyl]amino]phenyl]-2-furancarboxamide | Homo sapiens (human) | Potency | 39.8107 | 1 | 0 |
9,10-dimethoxy-2,4,6,7-tetrahydro-[1,3]oxazino[4,3-a]isoquinoline-1-carbonitrile | Homo sapiens (human) | Potency | 31.6228 | 1 | 0 |
6-methyl-2-[4-[oxo(thiophen-2-yl)methyl]-1-piperazinyl]-3-quinolinecarbonitrile | Homo sapiens (human) | Potency | 31.6228 | 1 | 0 |
[5-(2-furanyl)-7-(trifluoromethyl)-2-pyrazolo[1,5-a]pyrimidinyl]-[4-(2-pyridinyl)-1-piperazinyl]methanone | Homo sapiens (human) | Potency | 39.8107 | 1 | 0 |
5,7-dimethyl-2-(1-pyrrolidinyl)-3-quinolinecarbonitrile | Homo sapiens (human) | Potency | 25.1189 | 1 | 0 |
2-[[2-(1-azepanyl)-2-oxoethyl]thio]-6-methoxy-3-quinolinecarbonitrile | Homo sapiens (human) | Potency | 31.6228 | 1 | 0 |
8-[2-(4-methoxyphenyl)-5-phenyl-7-pyrazolo[1,5-a]pyrimidinyl]-1,4-dioxa-8-azaspiro[4.5]decane | Homo sapiens (human) | Potency | 31.6228 | 1 | 0 |
6-methoxy-3-[[[1-(2-methoxyethyl)-5-tetrazolyl]methyl-(3-pyridinylmethyl)amino]methyl]-1H-quinolin-2-one | Homo sapiens (human) | Potency | 31.6228 | 1 | 0 |
3-[3,4-dihydro-1H-isoquinolin-2-yl-[1-(2-methylbutan-2-yl)-5-tetrazolyl]methyl]-7-methoxy-1H-quinolin-2-one | Homo sapiens (human) | Potency | 12.5893 | 1 | 0 |
N-[(1,3-dimethyl-4-pyrazolyl)methyl]-5-(2-furanyl)-N-methyl-7-(trifluoromethyl)-2-pyrazolo[1,5-a]pyrimidinecarboxamide | Homo sapiens (human) | Potency | 31.6228 | 1 | 0 |
6-methoxy-3-[[2-oxolanylmethyl-[[1-(phenylmethyl)-5-tetrazolyl]methyl]amino]methyl]-1H-quinolin-2-one | Homo sapiens (human) | Potency | 31.6228 | 1 | 0 |
3-[[cyclopentyl-[[1-[(4-methoxyphenyl)methyl]-5-tetrazolyl]methyl]amino]methyl]-7-methyl-1H-quinolin-2-one | Homo sapiens (human) | Potency | 39.8107 | 1 | 0 |
5,8-dimethoxy-4-(4-methyl-1-piperazinyl)-2-(trifluoromethyl)quinoline | Homo sapiens (human) | Potency | 25.1189 | 1 | 0 |
N-(2,1,3-benzothiadiazol-4-yl)-3-(2-chloro-6-fluorophenyl)-5-methyl-4-isoxazolecarboxamide | Homo sapiens (human) | Potency | 31.6228 | 1 | 0 |
5-amino-2-(4-methylphenyl)isoindole-1,3-dione | Homo sapiens (human) | Potency | 25.1189 | 1 | 0 |
(6-fluoro-2-methyl-3,4-dihydro-2H-quinolin-1-yl)-[5-(2-furanyl)-7-(trifluoromethyl)-2-pyrazolo[1,5-a]pyrimidinyl]methanone | Homo sapiens (human) | Potency | 19.9526 | 1 | 0 |
2-cyano-N-(2-furanylmethyl)-2-[3-(4-morpholinyl)-2-quinoxalinyl]acetamide | Homo sapiens (human) | Potency | 31.6228 | 1 | 0 |
LSM-27020 | Homo sapiens (human) | Potency | 25.1189 | 1 | 0 |
2-cyano-2-[3-[4-(phenylmethyl)-1-piperazinyl]-2-quinoxalinyl]acetic acid 2-methoxyethyl ester | Homo sapiens (human) | Potency | 25.1189 | 1 | 0 |
N-ethyl-2-imino-10-methyl-1-[(4-methylphenyl)methyl]-5-oxo-3-dipyrido[3,4-c-1',2'-f]pyrimidinecarboxamide | Homo sapiens (human) | Potency | 1.5849 | 1 | 0 |
5-(2,4-dimethoxyphenyl)-7-(3,4-dimethoxyphenyl)-1,7-dihydrotetrazolo[1,5-a]pyrimidine | Homo sapiens (human) | Potency | 31.6228 | 1 | 0 |
3-methyl-N-(1-propyl-3-pyrazolo[3,4-b]quinolinyl)butanamide | Homo sapiens (human) | Potency | 25.1189 | 1 | 0 |
LSM-32147 | Homo sapiens (human) | Potency | 25.1189 | 1 | 0 |
2-cyano-2-[3-(4-morpholinyl)-2-quinoxalinyl]acetic acid hexyl ester | Homo sapiens (human) | Potency | 31.6228 | 1 | 0 |
2-[2-(dimethylamino)ethylthio]-6,6-dimethyl-5,8-dihydropyrano[4,5]thieno[1,2-c]pyrimidin-4-amine | Homo sapiens (human) | Potency | 15.8489 | 1 | 0 |
3-[[2-[4-[2-furanyl(oxo)methyl]-1-piperazinyl]-1-oxoethyl]amino]-6-methyl-1H-indole-2-carboxylic acid methyl ester | Homo sapiens (human) | Potency | 31.6228 | 1 | 0 |
N-(1,8-dimethyl-3-pyrazolo[3,4-b]quinolinyl)propanamide | Homo sapiens (human) | Potency | 12.5893 | 1 | 0 |
2-(3-methylphenyl)sulfonyl-2-[3-(1-pyrrolidinyl)-2-quinoxalinyl]acetonitrile | Homo sapiens (human) | Potency | 15.8489 | 1 | 0 |
N-(1-ethyl-7-methyl-3-pyrazolo[3,4-b]quinolinyl)-2-furancarboxamide | Homo sapiens (human) | Potency | 15.8489 | 1 | 0 |
1-(thiophen-2-ylmethyl)-3-thiophen-2-ylsulfonyl-2-pyrrolo[3,2-b]quinoxalinamine | Homo sapiens (human) | Potency | 25.1189 | 1 | 0 |
N-(1,7-dimethyl-3-pyrazolo[3,4-b]quinolinyl)acetamide | Homo sapiens (human) | Potency | 25.1189 | 1 | 0 |
5-(3-methoxyphenyl)-N-(2-oxolanylmethyl)-7-(trifluoromethyl)-3-pyrazolo[1,5-a]pyrimidinecarboxamide | Homo sapiens (human) | Potency | 31.6228 | 1 | 0 |
1-(4-methylphenyl)spiro[1,3-diazinane-5,4'-2,3,3a,5-tetrahydro-1H-pyrrolo[1,2-a]quinoline]-2,4,6-trione | Homo sapiens (human) | Potency | 25.1189 | 1 | 0 |
8-[[4-(4-fluorophenyl)-1-piperazinyl]methyl]-1,3-dimethyl-7-[2-(4-morpholinyl)ethyl]purine-2,6-dione | Homo sapiens (human) | Potency | 12.5893 | 1 | 0 |
N,N-diethyl-2-oxo-1H-benzo[cd]indole-6-sulfonamide | Homo sapiens (human) | Potency | 25.1189 | 1 | 0 |
6-methyl-4-(trifluoromethyl)-7,8,9,10-tetrahydropyrano[2,3-f]quinolin-2-one | Homo sapiens (human) | Potency | 0.5012 | 1 | 0 |
6-(4-morpholinyl)naphthalene-2,3-dicarbonitrile | Homo sapiens (human) | Potency | 25.1189 | 1 | 0 |
3-(5-methoxy-2,2-dimethyl-1-benzopyran-8-yl)-3-oxopropanoic acid | Homo sapiens (human) | Potency | 25.1189 | 1 | 0 |
1-[[4-(2-pyridinyl)-1-piperazinyl]methyl]-2-benzo[cd]indolone | Homo sapiens (human) | Potency | 25.1189 | 1 | 0 |
5-[2-(6-hydroxy-3-methyl-2-benzofuranyl)-2-oxoethyl]-2-furancarboxylic acid ethyl ester | Homo sapiens (human) | Potency | 25.1189 | 1 | 0 |
2-[[oxo(thiophen-2-yl)methyl]amino]-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylic acid propan-2-yl ester | Homo sapiens (human) | Potency | 25.1189 | 1 | 0 |
N-(2-ethylphenyl)-2-methoxy-5-methylbenzenesulfonamide | Homo sapiens (human) | Potency | 15.8489 | 1 | 0 |
curcumin | Homo sapiens (human) | Potency | 12.5893 | 1 | 0 |
4-[[[2,3-bis(2-pyridinyl)-6-quinoxalinyl]amino]-oxomethyl]-1-piperazinecarboxylic acid ethyl ester | Homo sapiens (human) | Potency | 15.8489 | 1 | 0 |
N-[4-[4-[(2-methylphenyl)-oxomethyl]-1-piperazinyl]phenyl]propanamide | Homo sapiens (human) | Potency | 25.1189 | 1 | 0 |
7-(difluoromethyl)-N-(5-methyl-3-isoxazolyl)-5-(4-methylphenyl)-3-pyrazolo[1,5-a]pyrimidinecarboxamide | Homo sapiens (human) | Potency | 19.9526 | 1 | 0 |
N-(2-furanylmethyl)-5-(4-methoxyphenyl)-7-(trifluoromethyl)-2-pyrazolo[1,5-a]pyrimidinecarboxamide | Homo sapiens (human) | Potency | 15.8489 | 1 | 0 |
N-(2-furanylmethyl)-5-thiophen-2-yl-7-(trifluoromethyl)-2-pyrazolo[1,5-a]pyrimidinecarboxamide | Homo sapiens (human) | Potency | 25.1189 | 1 | 0 |
ym-90709 | Homo sapiens (human) | Potency | 25.1189 | 1 | 0 |
6-bromo-3-(4-morpholinyl)-4-phenyl-1H-quinolin-2-one | Homo sapiens (human) | Potency | 31.6228 | 1 | 0 |
3,5-dimethyl-N-[2-(methylthio)phenyl]-4-isoxazolecarboxamide | Homo sapiens (human) | Potency | 12.5893 | 1 | 0 |
2-[[2-(3,4-dimethylanilino)-2-oxoethyl]thio]acetamide | Homo sapiens (human) | Potency | 19.9526 | 1 | 0 |
N-(2-furanylmethyl)-2-imino-5-oxo-1-(2-phenylethyl)-3-dipyrido[1,2-d-3',4'-f]pyrimidinecarboxamide | Homo sapiens (human) | Potency | 5.0119 | 1 | 0 |
2-[[4-cyano-6,6,7-trimethyl-1-(4-morpholinyl)-5,8-dihydro-2,7-naphthyridin-3-yl]thio]acetic acid methyl ester | Homo sapiens (human) | Potency | 3.1623 | 1 | 0 |
4-(dimethylsulfamoyl)-N-(1-ethyl-2-oxo-6-benzo[cd]indolyl)benzamide | Homo sapiens (human) | Potency | 31.6228 | 1 | 0 |
1-ethyl-N-[3-(4-morpholinyl)propyl]-2-oxo-6-benzo[cd]indolesulfonamide | Homo sapiens (human) | Potency | 15.8489 | 1 | 0 |
1-[2-(2-amino-3-cyano-1-pyrrolo[3,2-b]quinoxalinyl)ethyl]-3-phenylurea | Homo sapiens (human) | Potency | 25.1189 | 1 | 0 |
4-(3,4-dimethoxyphenyl)-1-(2-methoxyethyl)-4H-pyridine-3,5-dicarboxylic acid dimethyl ester | Homo sapiens (human) | Potency | 25.1189 | 1 | 0 |
3-[1-(3-methoxypropyl)-5-thiophen-2-yl-2-pyrrolyl]propanoic acid | Homo sapiens (human) | Potency | 15.8489 | 1 | 0 |
4-amino-2-[[4-(1-azepanylsulfonyl)phenyl]-oxomethyl]isoindole-1,3-dione | Homo sapiens (human) | Potency | 12.5893 | 1 | 0 |
3-[5-(2,5-dimethyl-1-phenyl-3-pyrrolyl)-1,3,4-oxadiazol-2-yl]-1-benzopyran-2-one | Homo sapiens (human) | Potency | 15.8489 | 1 | 0 |
2-(2-oxo-1-benzo[cd]indolyl)-N-(2-oxolanylmethyl)acetamide | Homo sapiens (human) | Potency | 25.1189 | 1 | 0 |
2-cyano-N-(phenylmethyl)-2-[3-(1-pyrrolidinyl)-2-quinoxalinyl]acetamide | Homo sapiens (human) | Potency | 25.1189 | 1 | 0 |
2-(3,4-dimethoxyphenyl)-4-quinolinecarboxylic acid (2-oxo-3-oxolanyl) ester | Homo sapiens (human) | Potency | 31.6228 | 1 | 0 |
3-(4-methylphenyl)sulfonyl-1-(3-oxolanylmethyl)-2-pyrrolo[3,2-b]quinoxalinamine | Homo sapiens (human) | Potency | 25.1189 | 1 | 0 |
1,4-dimethoxy-10H-acridine-9-thione | Homo sapiens (human) | Potency | 25.1189 | 1 | 0 |
9-chloro-6-methylindolo[3,2-b]quinoxaline | Homo sapiens (human) | Potency | 31.6228 | 1 | 0 |
3-[2-[butyl(methyl)amino]ethyl]-6-(4-morpholinyl)-2-sulfanylidene-1H-quinazolin-4-one | Homo sapiens (human) | Potency | 31.6228 | 1 | 0 |
4-[2-[(1'-acetyl-4-oxo-6-spiro[3,4-dihydro-2H-1-benzopyran-2,4'-piperidine]yl)oxy]-1-oxoethyl]-1-piperazinecarboxylic acid ethyl ester | Homo sapiens (human) | Potency | 25.1189 | 1 | 0 |
9-(4-methoxyphenyl)-3,3,6,6-tetramethyl-10-[2-(4-morpholinyl)ethyl]-4,5,7,9-tetrahydro-2H-acridine-1,8-dione | Homo sapiens (human) | Potency | 15.8489 | 1 | 0 |
2-chloro-6-[4-morpholinyl(oxo)methyl]-11-pyrido[2,1-b]quinazolinone | Homo sapiens (human) | Potency | 15.8489 | 1 | 0 |
N-[2-(3,4-diethoxyphenyl)ethyl]-1-[6-(4-morpholinyl)-3-pyridazinyl]-4-piperidinecarboxamide | Homo sapiens (human) | Potency | 15.8489 | 1 | 0 |
4-[[7-[(4-fluorophenyl)methyl]-1,3-dimethyl-2,6-dioxo-8-purinyl]methyl]-1-piperazinecarboxylic acid ethyl ester | Homo sapiens (human) | Potency | 25.1189 | 1 | 0 |
gw 7647 | Homo sapiens (human) | Potency | 39.8107 | 1 | 0 |
sto 609 | Homo sapiens (human) | Potency | 3.9811 | 1 | 0 |
1,3-dimethyl-8-[[methyl-(phenylmethyl)amino]methyl]-7-(2-methylpropyl)purine-2,6-dione | Homo sapiens (human) | Potency | 31.6228 | 1 | 0 |
N-(2-furanylmethyl)-2-[[5-[(2-methyl-1H-indol-3-yl)methyl]-1,3,4-oxadiazol-2-yl]thio]acetamide | Homo sapiens (human) | Potency | 19.9526 | 1 | 0 |
pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid | Homo sapiens (human) | Potency | 31.6228 | 1 | 0 |
fraxetin | Homo sapiens (human) | Potency | 17.9008 | 1 | 0 |
bilirubin | Homo sapiens (human) | Potency | 19.9526 | 1 | 0 |
scopoletin | Homo sapiens (human) | Potency | 3.4173 | 1 | 0 |
hymecromone | Homo sapiens (human) | Potency | 12.5893 | 1 | 0 |
esculetin | Homo sapiens (human) | Potency | 5.9622 | 1 | 0 |
7-hydroxycoumarin | Homo sapiens (human) | Potency | 15.8489 | 1 | 0 |
yangonin | Homo sapiens (human) | Potency | 31.6228 | 1 | 0 |
3,7,4'-trihydroxyflavone | Homo sapiens (human) | Potency | 12.5893 | 1 | 0 |
fisetin | Homo sapiens (human) | Potency | 17.9008 | 1 | 0 |
morin | Homo sapiens (human) | Potency | 15.8489 | 1 | 0 |
blebbistatin | Homo sapiens (human) | Potency | 31.6228 | 1 | 0 |
3-(3,4-dimethoxyphenyl)-5,7-dihydroxy-2-methyl-1-benzopyran-4-one | Homo sapiens (human) | Potency | 25.1189 | 1 | 0 |
4-methyl-2,3-dihydro-1,4-benzothiazine-6-carboxylic acid methyl ester | Homo sapiens (human) | Potency | 25.1189 | 1 | 0 |
8-(diethylaminomethyl)-7-hydroxy-4-phenyl-1-benzopyran-2-one | Homo sapiens (human) | Potency | 15.8489 | 1 | 0 |
irl 2500 | Homo sapiens (human) | Potency | 21.1069 | 3 | 0 |
ly 320135 | Homo sapiens (human) | Potency | 25.1189 | 1 | 0 |
6,7-dihydroxyflavone | Homo sapiens (human) | Potency | 25.1189 | 1 | 0 |
5,7-dihydroxy-4-methylcoumarin | Homo sapiens (human) | Potency | 25.1189 | 1 | 0 |
7-hydroxy-4-phenyl-8-(1-piperidinylmethyl)-1-benzopyran-2-one | Homo sapiens (human) | Potency | 3.1623 | 1 | 0 |
isoalloxazine | Homo sapiens (human) | Potency | 15.8489 | 1 | 0 |
2-(5,7-dihydroxy-4-methyl-2-oxo-1-benzopyran-3-yl)acetic acid ethyl ester | Homo sapiens (human) | Potency | 15.8489 | 1 | 0 |
6-ethyl-7-hydroxy-4-[[4-(2-hydroxyethyl)-1-piperazinyl]methyl]-1-benzopyran-2-one | Homo sapiens (human) | Potency | 10.0000 | 1 | 0 |
7-hydroxy-6-(4-morpholinylmethyl)-2,3-dihydro-1H-cyclopenta[c][1]benzopyran-4-one | Homo sapiens (human) | Potency | 25.1189 | 1 | 0 |
3-(1-benzimidazolyl)-6-ethyl-7-hydroxy-1-benzopyran-4-one | Homo sapiens (human) | Potency | 31.6228 | 1 | 0 |
3,7-dihydroxyflavone | Homo sapiens (human) | Potency | 15.8489 | 1 | 0 |
papaveroline | Homo sapiens (human) | Potency | 3.1623 | 1 | 0 |
3,5-di-tert-butylchalcone 4'-carboxylic acid | Homo sapiens (human) | Potency | 39.8107 | 1 | 0 |
nitrofurantoin | Homo sapiens (human) | Potency | 31.6228 | 1 | 0 |
bvt.948 | Homo sapiens (human) | Potency | 10.0000 | 1 | 0 |
LSM-6455 | Homo sapiens (human) | Potency | 25.1189 | 1 | 0 |
sepiapterin | Homo sapiens (human) | Potency | 12.5893 | 1 | 0 |
hematein | Homo sapiens (human) | Potency | 25.1189 | 1 | 0 |
7-hydroxyquinoline | Homo sapiens (human) | Potency | 15.8489 | 1 | 0 |
Protective effect of novel substituted nicotine hydrazide analogues against hypoxic brain injury in neonatal rats via inhibition of caspase.Bioorganic & medicinal chemistry letters, , 07-01, Volume: 26, Issue:13, 2016
Synthesis and evaluation of N-acyl-substituted 1,2-benzisothiazol-3-one derivatives as caspase-3 inhibitors.Bioorganic & medicinal chemistry, , Dec-15, Volume: 22, Issue:24, 2014
Synthesis and evaluation of isatin analogs as caspase-3 inhibitors: introduction of a hydrophilic group increases potency in a whole cell assay.Bioorganic & medicinal chemistry letters, , Apr-15, Volume: 21, Issue:8, 2011
Synthesis and evaluation of vinyl sulfones as caspase-3 inhibitors. A structure-activity study.European journal of medicinal chemistry, , Volume: 45, Issue:9, 2010
Synthesis and in vitro evaluation of sulfonamide isatin Michael acceptors as small molecule inhibitors of caspase-6.Journal of medicinal chemistry, , Apr-23, Volume: 52, Issue:8, 2009
Design, synthesis, and biological evaluation of isoquinoline-1,3,4-trione derivatives as potent caspase-3 inhibitors.Journal of medicinal chemistry, , Mar-09, Volume: 49, Issue:5, 2006
N-benzylisatin sulfonamide analogues as potent caspase-3 inhibitors: synthesis, in vitro activity, and molecular modeling studies.Journal of medicinal chemistry, , Dec-01, Volume: 48, Issue:24, 2005
Discovery of novel aspartyl ketone dipeptides as potent and selective caspase-3 inhibitors.Bioorganic & medicinal chemistry letters, , Feb-09, Volume: 14, Issue:3, 2004
Target | Category | Definition |
RNA binding | molecular function | Binding to an RNA molecule or a portion thereof. [GOC:jl, GOC:mah] |
aspartic-type endopeptidase activity | molecular function | Catalysis of the hydrolysis of internal, alpha-peptide bonds in a polypeptide chain by a mechanism in which a water molecule bound by the side chains of aspartic residues at the active center acts as a nucleophile. [ISBN:0198506732] |
cysteine-type endopeptidase activity | molecular function | Catalysis of the hydrolysis of internal, alpha-peptide bonds in a polypeptide chain by a mechanism in which the sulfhydryl group of a cysteine residue at the active center acts as a nucleophile. [GOC:mah, https://www.ebi.ac.uk/merops/about/glossary.shtml#CATTYPE, https://www.ebi.ac.uk/merops/about/glossary.shtml#ENDOPEPTIDASE] |
protein binding | molecular function | Binding to a protein. [GOC:go_curators] |
peptidase activity | molecular function | Catalysis of the hydrolysis of a peptide bond. A peptide bond is a covalent bond formed when the carbon atom from the carboxyl group of one amino acid shares electrons with the nitrogen atom from the amino group of a second amino acid. [GOC:jl, ISBN:0815332181] |
cysteine-type peptidase activity | molecular function | Catalysis of the hydrolysis of peptide bonds in a polypeptide chain by a mechanism in which the sulfhydryl group of a cysteine residue at the active center acts as a nucleophile. [GOC:mah, https://www.ebi.ac.uk/merops/about/glossary.shtml#CATTYPE] |
cysteine-type endopeptidase activity involved in apoptotic process | molecular function | Catalysis of the hydrolysis of internal, alpha-peptide bonds in a polypeptide chain by a mechanism in which the sulfhydryl group of a cysteine residue at the active center acts as a nucleophile, and contributing to the apoptotic process. [GOC:mtg_apoptosis] |
cysteine-type endopeptidase activity involved in execution phase of apoptosis | molecular function | Catalysis of the hydrolysis of internal, alpha-peptide bonds in a polypeptide chain by a mechanism in which the sulfhydryl group of a cysteine residue at the active center acts as a nucleophile, and contributing to the execution phase of apoptosis. [GOC:mtg_apoptosis, Wikipedia:Caspase] |
Target | Category | Definition |
proteolysis | biological process | The hydrolysis of proteins into smaller polypeptides and/or amino acids by cleavage of their peptide bonds. [GOC:bf, GOC:mah] |
apoptotic process | biological process | A programmed cell death process which begins when a cell receives an internal (e.g. DNA damage) or external signal (e.g. an extracellular death ligand), and proceeds through a series of biochemical events (signaling pathway phase) which trigger an execution phase. The execution phase is the last step of an apoptotic process, and is typically characterized by rounding-up of the cell, retraction of pseudopodes, reduction of cellular volume (pyknosis), chromatin condensation, nuclear fragmentation (karyorrhexis), plasma membrane blebbing and fragmentation of the cell into apoptotic bodies. When the execution phase is completed, the cell has died. [GOC:cjm, GOC:dhl, GOC:ecd, GOC:go_curators, GOC:mtg_apoptosis, GOC:tb, ISBN:0198506732, PMID:18846107, PMID:21494263] |
heart development | biological process | The process whose specific outcome is the progression of the heart over time, from its formation to the mature structure. The heart is a hollow, muscular organ, which, by contracting rhythmically, keeps up the circulation of the blood. [GOC:jid, UBERON:0000948] |
response to UV | biological process | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an ultraviolet radiation (UV light) stimulus. Ultraviolet radiation is electromagnetic radiation with a wavelength in the range of 10 to 380 nanometers. [GOC:hb] |
protein processing | biological process | Any protein maturation process achieved by the cleavage of a peptide bond or bonds within a protein. Protein maturation is the process leading to the attainment of the full functional capacity of a protein. [GOC:curators, GOC:jl, GOC:jsg] |
protein catabolic process | biological process | The chemical reactions and pathways resulting in the breakdown of a protein by the destruction of the native, active configuration, with or without the hydrolysis of peptide bonds. [GOC:mah] |
defense response to bacterium | biological process | Reactions triggered in response to the presence of a bacterium that act to protect the cell or organism. [GOC:jl] |
fibroblast apoptotic process | biological process | Any apoptotic process in a fibroblast, a connective tissue cell which secretes an extracellular matrix rich in collagen and other macromolecules. [CL:0000057, GOC:jl, GOC:mtg_apoptosis, GOC:yaf] |
striated muscle cell differentiation | biological process | The process in which a relatively unspecialized cell acquires specialized features of a striated muscle cell; striated muscle fibers are divided by transverse bands into striations, and cardiac and voluntary muscle are types of striated muscle. [CL:0000737, GOC:ai] |
neuron apoptotic process | biological process | Any apoptotic process in a neuron, the basic cellular unit of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the nervous system. [CL:0000540, GOC:mtg_apoptosis] |
protein maturation | biological process | Any process leading to the attainment of the full functional capacity of a protein. [GOC:ai] |
lymphocyte apoptotic process | biological process | Any apoptotic process in a lymphocyte, a leukocyte commonly found in the blood and lymph that has the characteristics of a large nucleus, a neutral staining cytoplasm, and prominent heterochromatin. [CL:0000542, GOC:add, GOC:mtg_apoptosis, ISBN:0781765196] |
cellular response to lipopolysaccharide | biological process | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria. [GOC:mah] |
cellular response to staurosporine | biological process | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a staurosporine stimulus. [GOC:mah] |
execution phase of apoptosis | biological process | A stage of the apoptotic process that starts with the controlled breakdown of the cell through the action of effector caspases or other effector molecules (e.g. cathepsins, calpains etc.). Key steps of the execution phase are rounding-up of the cell, retraction of pseudopodes, reduction of cellular volume (pyknosis), chromatin condensation, nuclear fragmentation (karyorrhexis), plasma membrane blebbing and fragmentation of the cell into apoptotic bodies. When the execution phase is completed, the cell has died. [GOC:mtg_apoptosis, PMID:21760595] |
positive regulation of plasma membrane repair | biological process | Any process that activates or increases the frequency, rate or extent of plasma membrane repair. [GO_REF:0000058, GOC:bhm, GOC:TermGenie, PMID:22940583] |
positive regulation of neuron apoptotic process | biological process | Any process that activates or increases the frequency, rate or extent of cell death of neurons by apoptotic process. [GOC:go_curators, GOC:mtg_apoptosis] |